Adolore Biotherapeutics, Inc. | WebDisclosure

Basculer en Français

8702	Companies
151439	Keywords
87080	Articles
81327	Press releases

Headlines Articles Press releases Adolore Biotherapeutics, Inc.

Home
Companies
Adolore Biotherapeutics, Inc.

BRIEF

published on 02/04/2025 at 23:05, 4 months ago

Adolore BioTherapeutics présentera les avancées en matière de thérapie génique au NANS 2025

Adolore BioTherapeutics Douleur Chronique Thérapie Génique Troubles Neurologiques NANS 2025
BRIEF

published on 02/04/2025 at 23:05, 4 months ago

Adolore BioTherapeutics to Present Gene Therapy Advancements at NANS 2025

Adolore BioTherapeutics Chronic Pain Gene Therapy Neurological Disorders NANS 2025
PRESS RELEASE

published on 02/04/2025 at 23:00, 4 months ago

Adolore BioTherapeutics to Present CA8* Neuromodulating Gene Therapy at the 2025 NANS Annual Meeting
Adolore BioTherapeutics to present CA8* chronic pain therapies and rdHSV delivery technology at 2025 NANS meeting. Company's focus on novel pain treatments highlighted

Adolore BioTherapeutics Neuromodulation CA8* Chronic Pain Therapies RdHSV Delivery Technology NANS
BRIEF

published on 10/02/2024 at 16:05, 8 months 3 days ago

Adolore BioTherapeutics to Present at 18th Annual Pain Therapeutics Summit

Adolore BioTherapeutics Chronic Pain Treatments Opioid Alternatives 18th Annual Pain Therapeutics Summit CA8* Analgesic Peptides
BRIEF

published on 10/02/2024 at 16:05, 8 months 3 days ago

Adolore BioTherapeutics présentera ses travaux au 18e Sommet annuel sur les thérapies contre la douleur

Adolore BioTherapeutics Traitements De La Douleur Chronique Alternatives Aux Opioïdes 18e Sommet Annuel Sur Les Thérapies Contre La Douleur Peptides Analgésiques CA8*
PRESS RELEASE

published on 10/02/2024 at 16:00, 8 months 3 days ago

Adolore BioTherapeutics to Present at 18th Annual Pain Therapeutics Summit
Adolore BioTherapeutics to present innovative opioid-free chronic pain treatments at the 18th Annual Pain Therapeutics Summit in Boston, Ma, based on cutting-edge CA8* analgesic peptides & rdHSV vectors technology

Adolore BioTherapeutics Opioid-free Chronic Pain Treatments CA8 Peptides RdHSV Vectors
BRIEF

published on 09/24/2024 at 14:25, 8 months 11 days ago

Adolore BioTherapeutics présentera son projet lors de l'événement Pitch de BioSparkVA

Adolore BioTherapeutics Douleur Chronique BioSparkVA Roy C. Levitt Thérapie Non Opioïde
BRIEF

published on 09/24/2024 at 14:25, 8 months 11 days ago

Adolore BioTherapeutics to Present at BioSparkVA Pitch Event

Adolore BioTherapeutics Chronic Pain Non-opioid Therapy BioSparkVA Roy C. Levitt
PRESS RELEASE

published on 09/24/2024 at 14:20, 8 months 11 days ago

Adolore BioTherapeutics to Present at BioSparkVA Pitch Event
Adolore BioTherapeutics to present innovative opioid-free chronic pain therapy at BioSpark Pitch Event. Programs for knee osteoarthritis & erythromelalgia in development

Adolore BioTherapeutics Chronic Pain Opioid-free Biotherapeutics Innovative Therapy
BRIEF

published on 07/30/2024 at 14:15, 10 months 6 days ago

Adolore BioTherapeutics Publishes Promising Preclinical Data on Non-Opioid Analgesic Gene Therapy

Adolore BioTherapeutics Chronic Pain Gene Therapy Osteoarthritis Non-opioid Analgesic

Accesswire

Published on 06/05/2025 at 17:15, 1 hour 32 minutes ago

Eagle Plains Clarifies OTCQB Venture Market Listing Symbol
Published on 06/05/2025 at 15:30, 3 hours 17 minutes ago

GPOPlus+ Announces the Launch of Call Center Operations to Expand Direct B2B Sales
Published on 06/05/2025 at 15:00, 3 hours 47 minutes ago

Grande Portage Announces Upsize of Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 06/05/2025 at 15:00, 3 hours 47 minutes ago

Vox Royalty Provides Development Updates Including Initial Construction Earthworks at the Sulphur Springs Copper Project in Australia
Published on 06/05/2025 at 15:00, 3 hours 47 minutes ago

Spetz Inc. Acquires 3.35m Sonic Tokens in First Week as Strategic Accumulation Program Commences

View all ACCESSWIRE

EQS Group

Published on 06/05/2025 at 18:00, 47 minutes ago

FLORENTAISE: En vue de la présentation d’un plan de continuation, Florentaise lance un processus de cession partielle de l’activité « Terreaux France Grand Public »
Published on 06/05/2025 at 17:45, 1 hour 2 minutes ago

FIGEAC AÉRO: MTI STRENGTHENS ITS POSITION ON NUCLEAR
Published on 06/05/2025 at 17:45, 1 hour 2 minutes ago

FIGEAC AÉRO: MTI ACCÉLÈRE SUR LE NUCLÉAIRE
Published on 06/05/2025 at 17:00, 1 hour 47 minutes ago

Dividend Declaration
Published on 06/05/2025 at 16:53, 1 hour 53 minutes ago

Halfords Group PLC: HOL-Holding(s) in Company

Les Echos

Published on 06/05/2025 at 18:00, 47 minutes ago

Déclaration des droits de vote à fin mai 2025
Published on 06/05/2025 at 17:58, 48 minutes ago

Shareholders’ Meeting on June 5, 2025
Published on 06/05/2025 at 17:58, 48 minutes ago

Assemblée Générale du 5 juin 2025
Published on 06/05/2025 at 17:35, 1 hour 12 minutes ago

Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 06/05/2025 at 16:10, 2 hours 36 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 mai 2025

View all LES ECHOS COMFI WIRE